Histone lactylation bridges metabolic reprogramming and epigenetic rewiring in driving carcinogenesis: Oncometabolite fuels oncogenic transcription
Clinical and Translational Medicine · 2024-03 · 14 (3)
DOI: 10.1002/ctm2.1614 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 08.03.2024. Verfasst von Yu Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Xuzhou Medical University, Xuzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Histones, Metabolic Reprogramming. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suzhou Municipal Health Commission, Science and Technology Program of Suzhou.
Abstract (Originalsprache)
Heightened lactate production in cancer cells has been linked to various cellular mechanisms such as angiogenesis, hypoxia, macrophage polarisation and T‐cell dysfunction. The lactate‐induced lactylation of histone lysine residues is noteworthy, as it functions as an epigenetic modification that directly augments gene transcription from chromatin. This epigenetic modification originating from lactate effectively fosters a reliance on transcription, thereby expediting tumour progression and development. Herein, this review explores the correlation between histone lactylation and cancer characteristics, revealing histone lactylation as an innovative epigenetic process that enhances the vulnerability of cells to malignancy. Moreover, it is imperative to acknowledge the paramount importance of acknowledging innovative therapeutic methodologies for proficiently managing cancer by precisely targeting lactate signalling. This comprehensive review illuminates a crucial yet inadequately investigated aspect of histone lactylation, providing valuable insights into its clinical ramifications and prospective therapeutic interventions centred on lactylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine, Xuzhou Medical University, Xuzhou, Jiangsu, China.
- Department of Ophthalmology, Peking Union Medical College Hospital, Beijing, China.
- Department of Ophthalmology, Eye Disease Prevention and Treatment Institute of Xuzhou, The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou First People's Hospital, Xuzhou, Jiangsu, China.
- Department of Ophthalmology, The First Affiliated Hospital of Soochow University, Suzhou, China.
ORCID-Profile: Peirong Lu
Förderung
- Suzhou Municipal Health Commission
- Science and Technology Program of Suzhou
Zitieren
APA
Zhang, Y., Song, H., Li, M., & Lu, P. (2024). Histone lactylation bridges metabolic reprogramming and epigenetic rewiring in driving carcinogenesis: Oncometabolite fuels oncogenic transcription. Clinical and Translational Medicine, 14(3). https://doi.org/10.1002/ctm2.1614
Vancouver
Zhang Y, Song H, Li M, Lu P. Histone lactylation bridges metabolic reprogramming and epigenetic rewiring in driving carcinogenesis: Oncometabolite fuels oncogenic transcription. Clinical and Translational Medicine. 2024;14(3). doi:10.1002/ctm2.1614
BibTeX
@article{Zhang2024,
author = {Zhang, Yu and Song, Hang and Li, Meili and Lu, Peirong},
title = {Histone lactylation bridges metabolic reprogramming and epigenetic rewiring in driving carcinogenesis: Oncometabolite fuels oncogenic transcription},
journal = {Clinical and Translational Medicine},
year = {2024},
volume = {14},
number = {3},
doi = {10.1002/ctm2.1614}
}
EUVIMED